Search

Search Constraints

You searched for: Author/Creator Sobue, Gen

Search Results

1. 046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP). Issue 6 (24th May 2018)

2. 17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study. Issue 3 (March 2020)

3. 18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment. Issue 3 (March 2020)

4. 19. Pharmacokinetic modelling and simulation of flexible dosing regimens of subcutaneous immunoglobulin (IgPro20) in CIDP patients. Issue 3 (March 2020)

5. 21. Exposure-response of serum IgG levels and INCAT scores in CIDP patients receiving subcutaneous immunoglobulin (IgPro20). Issue 3 (March 2020)

6. A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. Issue 8 (8th January 2016)

7. Aberrant Expression of Nodal and Paranodal Molecules in Neuropathy Associated With IgM Monoclonal Gammopathy With Anti-Myelin-Associated Glycoprotein Antibodies. Issue 12 (16th July 2020)

8. Age-related impairment in Addenbrooke's cognitive examination revised scores in patients with amyotrophic lateral sclerosis. Issue 7 (2nd October 2018)

9. ALS is a multistep process in South Korean, Japanese, and Australian patients. (14th April 2020)